π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The objective of this study is to assess the efficacy, safety of MRG003 as ...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences
Start Date
2020-09-04
Trial ID
NCT04838548
Treatments Being Tested
Initially, or after preoperative chemotherapy, patients with a kidney tumor...
Status
Unknown
Location
Dmitry Rogachev National Medical Research Centre of Pediatric Hematology, Oncology and Immunology
Start Date
2020-12-21
Trial ID
NCT04814758
Treatments Being Tested
The purpose of this study is to test a novel dendritic cell (DC) vaccine in...
Status
Completed
Location
Mary Crowley Medical Research Center: Baylor University Medical Center
Start Date
2005-07
Trial ID
NCT00125749
Treatments Being Tested
This study will evaluate the efficacy and safety of intravenous RC48-ADC co...
Status
Recruiting
Location
Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
Start Date
2022-11-23
Trial ID
NCT05917158
Treatments Being Tested
In Phase I, This study will explore the tolerability and safety of RC118 in...
Status
Recruiting
Location
Zhongshan Hospital Affiliated to Fudan University
Start Date
2022-03-03
Trial ID
NCT05205850
Treatments Being Tested
This is a first in human (FIH), Phase 1, dose escalation and expansion stud...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2026-04-21
Trial ID
NCT07612176
Treatments Being Tested
This is a single-arm, multicenter, phase II study designed to evaluate the ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-10
Trial ID
NCT07542717
Treatments Being Tested
RATIONALE: Vaccines made from a gene-modified virus and a person's white bl...
Status
Completed
Location
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Start Date
2005-02
Trial ID
NCT00103142
Treatments Being Tested
This study is an open-label, multicenter, first-in-human, Phase I, dose esc...
Status
Completed
Location
Breast Cancer Research Centre
Start Date
2022-09-02
Trial ID
NCT05494918
Treatments Being Tested
The objective of this study is to assess the safety, efficacy, pharmacokine...
Status
Unknown
Location
Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2022-01-19
Trial ID
NCT05141747
Treatments Being Tested